SCHEMBL2069016

SCHEMBL2069016

CCCCC(CC)CC=S

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP3A4 P08684 5/20 0.48
TSHR P16473 5/20 0.48
CA2 P00918 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.38
ATM Q13315 1/20 0.37
LMNA P02545 2/20 0.34
CYP2D6 P10635 2/20 0.34
CHRM2 P08172 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
CHRM1 P11229 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
OPRM1 P35372 1/20 0.34
DRD3 P35462 1/20 0.34
SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12792705 0.86 ALDH1A1 (0.39) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL4653061 0.80 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL23925189 0.80 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL23925191 0.80 ALDH1A1 (0.54) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL277001 0.79 LMNA (0.43) ALDH1A1TDP1CYP3A4TSHRLMNA
SCHEMBL276996 0.79
SCHEMBL3896660 0.78 ALDH1A1 (0.52) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL4920279 0.76 ALDH1A1 (0.50) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL78112 0.76 TSHR (0.54) ALDH1A1TDP1CYP3A4TSHRCA2
SCHEMBL7643016 0.76 ALDH1A1 (0.56) ALDH1A1TDP1CYP3A4TSHRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9711737-B2 Photoelectric conversion element and solid-state imaging device SONY CORPORATION (JP) 2017-07-18 US claimed
US-20160049595-A1 PHOTOELECTRIC CONVERSION ELEMENT AND SOLID-STATE IMAGING DEVICE SONY CORPORATION (JP) 2016-02-18 US claimed
US-9123901-B2 Photoelectric conversion element and solid-state imaging device SONY CORPORATION (JP) 2015-09-01 US claimed
EP-2478981-B1 SILVER-(CONJUGATED COMPOUND) COMPLEX SUMITOMO CHEMICAL CO (JP) 2020-12-23 EP disclosed
US-9711737-B2 Photoelectric conversion element and solid-state imaging device SONY CORPORATION (JP) 2017-07-18 US disclosed
US-9704612-B2 Composition of silver-conjugated compound composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-11 US disclosed
US-9412487-B2 Silver-(conjugated compound) composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-08-09 US disclosed
US-20160049595-A1 PHOTOELECTRIC CONVERSION ELEMENT AND SOLID-STATE IMAGING DEVICE SONY CORPORATION (JP) 2016-02-18 US disclosed
US-9123901-B2 Photoelectric conversion element and solid-state imaging device SONY CORPORATION (JP) 2015-09-01 US disclosed
US-8963142-B2 Photoelectric transducer and solid-state imaging apparatus SONY CORPORATION (JP) 2015-02-24 US disclosed
EP-2546257-B1 BISPHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING SAME UNIV TOHOKU NAT UNIV CORP (JP) 2014-08-27 EP disclosed
US-20120330038-A1 BIS-PHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING THE SAME API CORPORATION (JP) 2012-12-27 US disclosed
EP-2478981-A1 SILVER-(CONJUGATED COMPOUND) COMPLEX Sumitomo Chemical Co., Ltd (JP) 2012-07-25 EP disclosed
US-20120168693-A1 SILVER-(CONJUGATED COMPOUND) COMPOSITE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-05 US disclosed
US-7902207-B2 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-03-08 US disclosed
US-7781425-B2 Guanidine compound and asymmetric reaction using the same TAKASAGO INTERNATIONAL COPORATION (JP) 2010-08-24 US disclosed
US-20080154036-A1 Guanidine Compound and Asymmetric Reaction Using the Same TAKASAGO INTERNATIONAL CORPORATION (JP) 2008-06-26 US disclosed
US-7312347-B2 Substituted optically active disphosphine compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-12-25 US disclosed
US-20070142639-A1 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
US-20070073065-A1 Substituted optically active disphosphine compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154036-A1 Guanidine Compound and Asymmetric Reaction Using the Same GEMIN5, PRMT5, SMS ALDH1A1 2039/4885TDP1 3674/4885CYP3A4 148/4885
US-20070142639-A1 Process for production of amines SMS, CCNT1, PEAK1 ALDH1A1 1001/4885TDP1 2750/4885CYP3A4 507/4885
US-20070073065-A1 Substituted optically active disphosphine compound DHPS, DOHH, DHODH ALDH1A1 277/4885TDP1 3874/4885CYP3A4 374/4885
US-20120330038-A1 BIS-PHOSPHATE COMPOUND AND ASYMMETRIC REACTION USING THE SAME AASDHPPT, ALDH7A1, ATIC ALDH1A1 342/4885TDP1 2935/4885CYP3A4 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.